SRNE

Sorrento Therapeutics, Inc.
SRNE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SRNE was delisted on the 22nd of February, 2023.

Back to rankings

46 hedge funds and large institutions have $25M invested in Sorrento Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

52% less capital invested

Capital invested by funds: $52.4M → $25M (-$27.5M)

59% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 29

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13K
Puts
$9K
Net Calls
Net Calls Change

Top Buyers

1
+$1.13M
2
+$980K
3
+$779K
4
Goldman Sachs
Goldman Sachs
New York
+$502K
5
ECM
Element Capital Management
New York
+$439K

Top Sellers

1
-$2.13M
2
-$1.55M
3
-$1.14M
4
State Street
State Street
Massachusetts
-$984K
5
VIA
Vident Investment Advisory
Georgia
-$674K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
1 2
3